NeoGenomics, Inc. (NGNM.OB) Receives Q1 2009 Stock Valuation Report
AMI Research, a division of Hawk Associates, announced this morning that it has updated its stock valuation report of NeoGenomics, Inc. (OTCBB: NGNM) based on the company's first quarter results. The complete 16-page report is available at http://www.amistockreports.com/NGNM_Q109Update.html. NeoGenomics specializes in cancer genetics, flow cytometry and molecular diagnostic testing. Headquartered in Fort Myers, FL, the company has laboratories in Nashville, TN, Irvine, CA and Fort Myers and provides diagnostic tests to pathologists, oncologists, urologists, and hospitals throughout the United States. In summary, the AMI Research report stated, “We like management’s focus on long term sustainable value creation rather than short…